← Leaderboards
Danielle Ahn
Columbia University Health Sciences
$981,204
Attributed
$981,204
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $166.2K · FY2017–25$200K$150K$100K$50K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$981,204 · 2
By mechanism
K08$734,454 · 1
R03$246,750 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Anne-Catrin Uhlemann$11,456,359
- Medini K Annavajhala$1,283,298
- Thomas Howe McConville$962,280
- Tania Wong Fok Lung$2,901,050
- Jeffrey D. Edwards$565,275
Others in their field
Other Emerging Leaders on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$49,374,001
- Prasant Mohapatra · University Of California At Davis$40,346,250
- Greg Yothers · University Of Chicago$35,003,821
Research focus
LungPublic HealthFoundationsIn VivoPneumoniaOrganismCytokineExperimental StudyImpairmentInnovationPhenotypeMutantAttenuationBacteriaCellsCritical IllnessAntimicrobialDisease ModelCessation Of LifeImmuneInfectionInflammatoryAffectResearch Personnel
Grant awards (7)
Host immunity in the lung is determined by the enhanced utilization of glucose by multi-drug resistant Klebsiella pneumoniae$123,375
R03 · FY2025 · HL · contact PI
Host immunity in the lung is determined by the enhanced utilization of glucose by multi-drug resistant Klebsiella pneumoniae$123,375
R03 · FY2024 · HL · contact PI
Host-pathogen interactions that promote carbapenem-resistantÃÂ Klebsiella pneumoniaeÃÂ pulmonary infection$69,606
K08 · FY2021 · HL · contact PI
Host-pathogen interactions that promote carbapenem-resistantÃÂ Klebsiella pneumoniaeÃÂ pulmonary infection$166,212
K08 · FY2020 · HL · contact PI
Host-pathogen interactions that promote carbapenem-resistant Klebsiella pneumoniae pulmonary infection$166,212
K08 · FY2019 · HL · contact PI
Host-pathogen interactions that promote carbapenem-resistant Klebsiella pneumoniae pulmonary infection$166,212
K08 · FY2018 · HL · contact PI
Host-pathogen interactions that promote carbapenem-resistant Klebsiella pneumoniae pulmonary infection$166,212
K08 · FY2017 · HL · contact PI